Assertio Holdings, Inc. Announces the Acquisition of Otrexup® (methotrexate) a Drug Device Combination from Antares Pharma, Inc.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

United States ,Max Nemmers ,Dan Peisert ,Company Nasdaq ,Assertio Holdings Inc ,Nasdaq ,Teva Pharmaceutical Industries Ltd ,Exchange Commission ,Pfizer ,Pfizer Inc ,Antares Pharma ,Securities Exchange ,Idorsia Pharmaceuticals Ltd ,Antares Pharma Inc ,Zyla Life Sciences The Merger ,Reported Revenues ,Otrexup Were ,Pay Antares ,Full Year Net Product Sales ,Chief Executive Officer ,Product Sales ,Expire Orange Book Listed ,Revenue Ended ,Teva Pharmaceutical Industries ,Idorsia Pharmaceuticals ,Sumatriptan Injection ,Investor Relations ,Securities Act ,Securities Exchange Act ,Zyla Life Sciences ,United States Securities ,Annual Report ,Quarterly Reports ,Technology ,Business ,Health ,Globe Newswire ,